Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center Meeting Abstract


Authors: Fontes Santos De Teive Argolo, D.; Smyth, L. M.; Iyengar, N. M.; Patil, S.; Norton, L.; Baselga, J.; Hudis, C. A.; Dang, C. T.
Abstract Title: Trastuzumab and pertuzumab-based versus other therapy as second-line therapy in HER2-positive metastatic breast cancer: A retrospective study from single center
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036901408
PROVIDER: wos
Notes: Meeting Abstract: 616 -- Source: Wos
MSK Authors
  1. Sujata Patil
    365 Patil
  2. Clifford Hudis
    818 Hudis
  3. Larry Norton
    543 Norton
  4. Chau Dang
    153 Dang
  5. Neil Mukund Iyengar
    62 Iyengar
  6. Jose T Baselga
    389 Baselga
  7. Lillian   Smyth
    20 Smyth